Trial intelligence / Profile preview

Low-dose hCG adjunct to r-hFSH plus GnRH antagonist for ovarian stimulation in assisted reproductive technology

IRCT201211197165N2Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Nov 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2 trial of human chorionic gonadotropin and recombinant human follicle stimulating hormone in infertility (2 arms), sponsored by Tehran University of Medical Sciences. Started Nov 2012; status: completed.

02

Drugs

human chorionic gonadotropinrecombinant human follicle stimulating hormone
03

Conditions

infertility

Beyond the preview

Go deeper on IRCT201211197165N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201211197165N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call